Issue 36, 2022

Studies on the synthesis of 1′-CN-triazolyl-C-ribosides

Abstract

The search for broad-spectrum antiviral compounds is a continuous mandatory effort. The recent approval of the first C-nucleoside carrying a nitrile as a substituent at the C1′ position of the ribose ring has raised interest in this underexplored substitution pattern. We have previously reported the development of different 1,2,3-triazolyl-C-ribonucleosides with anticancer and antiviral activities. Herein we report our results on the incorporation of a C1′–CN group in 1,2,3-triazolyl-C-ribonucleosides.

Graphical abstract: Studies on the synthesis of 1′-CN-triazolyl-C-ribosides

Supplementary files

Article information

Article type
Paper
Submitted
01 Aug 2022
Accepted
30 Aug 2022
First published
07 Sep 2022

Org. Biomol. Chem., 2022,20, 7261-7269

Studies on the synthesis of 1′-CN-triazolyl-C-ribosides

N. Bozinovic, V. M. D. Aguiar, A. Ferry, F. Gallier, N. Lubin-Germain, J. Uziel and L. S. D. M. E. Miranda, Org. Biomol. Chem., 2022, 20, 7261 DOI: 10.1039/D2OB01403C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements